EPAS1 and neuroblastoma: The results in this study are consistent with an earlier study wherein dual treatment of neuroblastoma cells with the demethylating agent 5-Aza-2’-deoxycytidine and retinoic acid inhibited xenografted tumor growth while inducing EPAS1 expression along with several HIF2α target genes (6).